3.97
price down icon0.50%   -0.02
after-market After Hours: 3.95 -0.02 -0.50%
loading
Dermata Therapeutics Inc stock is traded at $3.97, with a volume of 30,184. It is down -0.50% in the last 24 hours and down -28.85% over the past month. Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.
See More
Previous Close:
$3.99
Open:
$4
24h Volume:
30,184
Relative Volume:
0.25
Market Cap:
$2.71M
Revenue:
-
Net Income/Loss:
$-11.27M
P/E Ratio:
-0.1854
EPS:
-21.4132
Net Cash Flow:
$-9.40M
1W Performance:
-4.34%
1M Performance:
-28.85%
6M Performance:
-45.54%
1Y Performance:
-74.87%
1-Day Range:
Value
$3.914
$4.13
1-Week Range:
Value
$3.83
$4.44
52-Week Range:
Value
$3.83
$23.70

Dermata Therapeutics Inc Stock (DRMA) Company Profile

Name
Name
Dermata Therapeutics Inc
Name
Phone
(858)-223-0882
Name
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2024-08-15
Name
Latest SEC Filings
Name
DRMA's Discussions on Twitter

Compare DRMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
DRMA
Dermata Therapeutics Inc
3.97 2.72M 0 -11.27M -9.40M -21.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Dermata Therapeutics Inc Stock (DRMA) Latest News

pulisher
02:23 AM

Technical analysis overview for Dermata Therapeutics Inc. Equity Warrant stockM&A Rumor & High Accuracy Swing Trade Signals - newser.com

02:23 AM
pulisher
11:56 AM

Is Dermata Therapeutics Inc. Equity Warrant stock a top pick in earnings seasonBuy Signal & Low Drawdown Investment Ideas - Trung tâm Dự báo KTTV quốc gia

11:56 AM
pulisher
11:23 AM

Market Outlook: How interest rate cuts could boost Dermata Therapeutics Inc. stock2025 Stock Rankings & Capital Efficiency Focused Ideas - Trung tâm Dự báo KTTV quốc gia

11:23 AM
pulisher
09:18 AM

Short interest data insights for Dermata Therapeutics Inc. Equity WarrantJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

09:18 AM
pulisher
01:35 AM

Chart overlay techniques for tracking Dermata Therapeutics Inc. Equity WarrantJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com

01:35 AM
pulisher
Oct 16, 2025

Analyzing Dermata Therapeutics Inc. Equity Warrant with risk reward ratio chartsJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Is Dermata Therapeutics Inc. Equity Warrant meeting your algorithmic filter criteriaPortfolio Risk Summary & High Win Rate Trade Tips - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Applying Elliott Wave Theory to Dermata Therapeutics Inc.2025 Market Overview & Technical Confirmation Alerts - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

What analysts say about Dermata Therapeutics Inc Equity Warrant stockLarge Cap Stability Picks & Receive Monthly Expert Trading Blueprints - earlytimes.in

Oct 15, 2025
pulisher
Oct 15, 2025

Analyzing drawdowns of Dermata Therapeutics Inc. with statistical toolsEarnings Trend Report & Weekly Stock Breakout Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Is Dermata Therapeutics Inc. Equity Warrant stock poised for growthJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Risk vs reward if holding onto Dermata Therapeutics Inc. Equity WarrantBreakout Watch & Advanced Swing Trade Entry Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Can Expleo Solutions Limited Survive Disruption in Its Core IndustryREITs Market Trends & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in

Oct 14, 2025
pulisher
Oct 14, 2025

How buybacks impact Dermata Therapeutics Inc. Equity Warrant stock valueJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

What valuation multiples suggest for Dermata Therapeutics Inc. Equity Warrant stockMarket Activity Recap & Daily Volume Surge Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Why Dermata Therapeutics Inc. stock could outperform in 2025Weekly Investment Recap & Entry Point Confirmation Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc. Equity Warrant2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Momentum divergence signals in Dermata Therapeutics Inc. Equity Warrant chartEarnings Recap Report & Fast Moving Stock Watchlists - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to monitor Dermata Therapeutics Inc. Equity Warrant with trend dashboardsJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Developing predictive dashboards with Dermata Therapeutics Inc. dataJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Pattern recognition hints at Dermata Therapeutics Inc. upsideWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Historical volatility pattern of Dermata Therapeutics Inc. visualizedPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com

Oct 11, 2025
pulisher
Oct 11, 2025

Dermata Therapeutics announces $2.55M private offering - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

Using R and stats models for Dermata Therapeutics Inc. forecastingJuly 2025 Outlook & Short-Term High Return Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Analyzing drawdowns of Dermata Therapeutics Inc. Equity Warrant with statistical tools2025 Risk Factors & Reliable Breakout Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Does Dermata Therapeutics Inc. qualify in momentum factor screeningMarket Risk Analysis & Weekly High Potential Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why Dermata Therapeutics Inc. stock remains a top recommendationJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Will Dermata Therapeutics Inc. Equity Warrant price bounce be sustainableEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What drives Dermata Therapeutics Inc stock priceMarket Correction Analysis & Low Risk Investment Tips - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 07, 2025
pulisher
Oct 06, 2025

News impact scoring models applied to Dermata Therapeutics Inc. Equity Warrant2025 Price Momentum & Smart Money Movement Tracker - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What the charts say about Dermata Therapeutics Inc. Equity Warrant today2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Why Dermata Therapeutics Inc. Equity Warrant stock is a must watch in 2025Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Measuring Dermata Therapeutics Inc. Equity Warrant’s beta against major indicesJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What momentum shifts mean for Dermata Therapeutics Inc. Equity WarrantWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga

Oct 03, 2025

Dermata Therapeutics Inc Stock (DRMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Cap:     |  Volume (24h):